Friday 6 November 2026
Export ATR’s income statement to Excel — free account
AptarGroup, Inc.
ATR Healthcare Medical Instruments & Supplies
AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.
- Revenue
- +6.03%
- EPS
- −73.9%
- Free cash flow
- −16.9%
- Total debt
- +14.6%
Quarter to September 2026, against a year earlier
143.84
3.02
−2.06%
Follow ATR
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 6 | 6 | 6 |
| 15.19% | 14.87% | 13.52% | 9.86% | ||
| 8.11% | 8.03% | 7.25% | 5.23% | ||
ROIC |
8.33% | 8.18% | 7.82% | 7.83% | |
Return on Tangible Assets |
16.34% | 16.34% | 15.46% | 11.88% | |
Average Days of Receivables |
77.68 | 78.53 | 83.30 | 80.84 | |
Free Cash Flow per Share |
4.53 | 5.13 | 4.94 | 4.64 | |
Free Cash Flow |
298.11 | 328.66 | 314.58 | 295.02 | |
Capital Expenditures |
(271.89) | (277.29) | (268.89) | (278.45) | |
| Other line items | |||||
Cash ROIC |
6.51% | 7.75% | 7.47% | 6.99% | |
Accounts Receivable Turnover |
5.17 | 4.91 | 4.63 | 4.74 | |
Accounts Payable Turnover |
3.06 | 3.06 | 2.95 | 2.99 | |
Inventory Turnover |
4.75 | 4.74 | 4.54 | 4.54 | |
Average Days of Payables |
126.60 | 125.14 | 128.80 | 124.22 | |
Days of Inventory on Hand |
82.75 | 82.08 | 84.21 | 82.98 | |
Tax Rate |
(0.20) | (0.19) | (0.20) | (0.26) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
16.06% | 15.98% | 15.90% | 15.96% | |
Share Based Compensation of Revenue |
1.16% | 1.07% | 1.04% | 1.01% | |
Interest Coverage |
9.50 | 8.49 | 7.52 | 7.23 | |
Operating CF/Net income |
1.45 | 1.57 | 1.61 | 2.15 | |
Depreciation/Fixed assets |
0.17 | 0.18 | 0.19 | 0.19 | |
Capex/Depreciation |
(0.95) | (0.93) | (0.88) | (0.91) | |
Revenue per Share |
57.46 | 60.46 | 61.81 | 62.83 | |
Operating CF per Share |
8.67 | 9.46 | 9.17 | 9.03 | |
Capex per Share |
(4.14) | (4.33) | (4.23) | (4.38) | |
Capex to Sales |
0.07 | 0.07 | 0.07 | 0.07 |
Columns are period end dates · fundamentals updated 5 Nov 2026